Evolus Inc Stock
Evolus Inc Stock
Evolus Inc took a tumble today and lost -€1.957 (-13.590%).
Based on 1 Buy predictions and 2 Sell predictions the sentiment towards Evolus Inc is rather balanced.
The target price of €5.00 compared with the current price of €10.20 for the stock indicates a negative potential of -50.956%.
For the coming years our community has positive and negative things to say abot the Evolus Inc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Based on 1 Buy predictions and 2 Sell predictions the sentiment towards Evolus Inc is rather balanced.
The target price of €5.00 compared with the current price of €10.20 for the stock indicates a negative potential of -50.956%.
For the coming years our community has positive and negative things to say abot the Evolus Inc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Evolus Inc in the next few years
Performance of Evolus Inc vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Evolus Inc | -13.590% | 25.585% | 71.229% | 52.164% | 264.628% | - | - |
| Harrow Health Inc. | -8.090% | 7.937% | -12.821% | 30.769% | 47.186% | - | - |
| Novavax Inc. | 11.780% | -27.420% | -43.686% | 1195.490% | 36.734% | 286.374% | 48.572% |
| Vanda Pharmaceuticals | 0.680% | -8.176% | 22.689% | - | 37.736% | - | - |